Correction to: Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Works matching IS 15272729 AND DT 2025 AND VI 26 AND IP 2
Results: 7
1
2
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 142, doi. 10.1007/s11864-025-01293-w
- By:
- Publication type:
- Article
3
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 73, doi. 10.1007/s11864-025-01292-x
- By:
- Publication type:
- Article
4
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 84, doi. 10.1007/s11864-025-01291-y
- By:
- Publication type:
- Article
5
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 128, doi. 10.1007/s11864-025-01290-z
- By:
- Publication type:
- Article
6
Advancements in Diagnosis and Treatment of Cardiac Sarcomas: A Comprehensive Review.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 103, doi. 10.1007/s11864-024-01287-0
- By:
- Publication type:
- Article
7
Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms.
- Published in:
- Current Treatment Options in Oncology, 2025, v. 26, n. 2, p. 92, doi. 10.1007/s11864-024-01283-4
- By:
- Publication type:
- Article